Pfiz­er, Bris­tol My­ers dom­i­nate top 10 pre­dic­tions for the best-sell­ing drugs of 2022

The an­nu­al ex­er­cise where an­a­lysts try and pre­dict which drugs will be­come block­busters and make the most mon­ey tends to high­light the biggest trends in bio­phar­ma R&D. 2022 is no ex­cep­tion.

The team at Eval­u­ate Van­tage pub­lished its pre­dic­tions for the top 10 sell­ing drugs for the year — ex­pect­ing tens of bil­lions of dol­lars in sales and high­light­ing an in­dus­try-wide fo­cus on cer­tain dis­eases and in­di­ca­tions.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER